N-Nitroso-N-methylurea

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for N-Nitroso-N-methylurea

Articles

Most recent articles on N-Nitroso-N-methylurea

Most cited articles on N-Nitroso-N-methylurea

Review articles on N-Nitroso-N-methylurea

Articles on N-Nitroso-N-methylurea in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on N-Nitroso-N-methylurea

Images of N-Nitroso-N-methylurea

Photos of N-Nitroso-N-methylurea

Podcasts & MP3s on N-Nitroso-N-methylurea

Videos on N-Nitroso-N-methylurea

Evidence Based Medicine

Cochrane Collaboration on N-Nitroso-N-methylurea

Bandolier on N-Nitroso-N-methylurea

TRIP on N-Nitroso-N-methylurea

Clinical Trials

Ongoing Trials on N-Nitroso-N-methylurea at Clinical Trials.gov

Trial results on N-Nitroso-N-methylurea

Clinical Trials on N-Nitroso-N-methylurea at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on N-Nitroso-N-methylurea

NICE Guidance on N-Nitroso-N-methylurea

NHS PRODIGY Guidance

FDA on N-Nitroso-N-methylurea

CDC on N-Nitroso-N-methylurea

Books

Books on N-Nitroso-N-methylurea

News

N-Nitroso-N-methylurea in the news

Be alerted to news on N-Nitroso-N-methylurea

News trends on N-Nitroso-N-methylurea

Commentary

Blogs on N-Nitroso-N-methylurea

Definitions

Definitions of N-Nitroso-N-methylurea

Patient Resources / Community

Patient resources on N-Nitroso-N-methylurea

Discussion groups on N-Nitroso-N-methylurea

Patient Handouts on N-Nitroso-N-methylurea

Directions to Hospitals Treating N-Nitroso-N-methylurea

Risk calculators and risk factors for N-Nitroso-N-methylurea

Healthcare Provider Resources

Symptoms of N-Nitroso-N-methylurea

Causes & Risk Factors for N-Nitroso-N-methylurea

Diagnostic studies for N-Nitroso-N-methylurea

Treatment of N-Nitroso-N-methylurea

Continuing Medical Education (CME)

CME Programs on N-Nitroso-N-methylurea

International

N-Nitroso-N-methylurea en Espanol

N-Nitroso-N-methylurea en Francais

Business

N-Nitroso-N-methylurea in the Marketplace

Patents on N-Nitroso-N-methylurea

Experimental / Informatics

List of terms related to N-Nitroso-N-methylurea


Template:Chembox AbbreviationsTemplate:Chembox BeilsteinTemplate:Chembox ECNumberTemplate:Chembox E numberTemplate:Chembox LogPTemplate:Chembox pKaTemplate:Chembox pKbTemplate:Chembox OtherFunctn
N-Nitroso-N-methylurea
Skeletal formula of N-nitroso-N-methylurea
Template:Chembox image sbs cell
Names
IUPAC name
1-Methyl-1-nitrosourea[1]
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
MeSH Methylnitrosourea
Properties
C2H5N3O2
Molar mass 103.08 g·mol−1
Related compounds
Related compounds
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Overview

N-Nitroso-N-methylurea (NMU) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids, which can lead to AT:GC transition mutations.

NMU is the traditional precursor in the synthesis of diazomethane. However, since it is unstable at temperatures beyond 20 °C and shock-sensitive to a degree, for this purpose it has become obsolete and replaced by other (N-methyl)nitrosamides. Most chemical supply houses have stopped carrying it.

Acute exposure to NMU in humans can result in skin and eye irritation, headache, nausea, and vomiting.[2] NMU is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals (IARC 1972, 1978, 1987).[3] Various cancers induced in animal models include: squamous cell carcinomas of the forestomach, sarcomas and gliomas of the brain, adenocarcinomas of the pancreas, leukemia, and lymphomas.[3] However, the actual potential for human exposure is quite limited, as the chemical is not produced or used in large quantities [3]

NMU is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation.[4][5][6] Exposure to NMU during pre-implantation, post-implantation, organogenesis, or by paternal exposure can result in these effects.

References

  1. ↑ "Methylnitrosourea - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 26 March 2005. Identification. Retrieved 1 May 2012.
  2. ↑ Hazardous Substance Fact Sheet for NMU New Jersey Department of Health and Senior Services
  3. ↑ 3.0 3.1 3.2 NMU Substance Profile NTP, Report on Carcinogens, Eleventh Edition
  4. ↑ Wada, A., et al. (1994). Induction of Congenital Malformations in Mice by Paternal Methylnitrosourea Treatment. Congenital Anomalies 34:65-70.
  5. ↑ Nagao, T., et al. (1991). Induction of Fetal Malformations After Treatment of Mouse Embryos with Methylnitrosourea at the Preimplantation Stages. Teratogenesis, Carcinogenesis, and Mutagenesis 11:1-10.
  6. ↑ Faustman, E., et al. (1989). In Vitro Developmental Toxicity of Five Direct-Acting Alkylating Agents in Rodent Embryos: Structure-Activity Patterns. Teratology 40:199-210.